山東省眼科醫(yī)院
醫(yī)院概覽
山東省眼科醫(yī)院于2004年由中國工程院院士---謝立信教授創(chuàng)辦，是山東省委省政府做大做強 “山東大眼科”，發(fā)揮院士效應的重要舉措，是山東省眼科研究所“做大做強”的重要步驟，也是國內(nèi)最大的集醫(yī)療、教學、科研、防盲為一體的國有省級三級甲等眼科?？漆t(yī)院之一。
作為院士單位，我院具備國內(nèi)突出、省內(nèi)領先的人才、技術(shù)、科研優(yōu)勢。醫(yī)院由院士創(chuàng)辦，亞洲角膜病協(xié)會副主席以及中華醫(yī)學會眼科學分會常委、角膜病學組組長由我院專家擔任。省內(nèi)眼科唯一的山東省醫(yī)學領軍人才亦在我院。
醫(yī)院是我國角膜病診療、科研的龍頭單位，全國最主要的角膜移植手術(shù)中心之一。在各種眼燒傷、角膜感染、圓錐角膜、飛秒激光輔助的角膜移植、內(nèi)皮移植等疑難角膜病治療方面具有突出的專家、技術(shù)優(yōu)勢和創(chuàng)新能力。是國內(nèi)唯一出版角膜病系列專著（前后共5部，500余萬字）的單位。還是國內(nèi)疑難白內(nèi)障、兒童白內(nèi)障、視網(wǎng)膜眼底疾病診療的重要基地，是國內(nèi)極少數(shù)能夠完成眼部大貫穿手術(shù)（角膜移植聯(lián)合玻璃體切除治療復雜眼外傷等眼前后段聯(lián)合手術(shù)）的單位之一。
在世界眼科領域權(quán)威學術(shù)雜志《Ophthalmology》發(fā)表文章10余篇，排行國內(nèi)第一。憑借在角膜及眼表手術(shù)方面的多項創(chuàng)新，榮獲國家科技進步二等獎2項，是近20年來省內(nèi)唯一獲得2項國家科技進步獎二等獎的單位。
自2008年起，醫(yī)院先后被省有關部門批準為山東省眼科臨床專業(yè)質(zhì)量控制中心、山東省眼科醫(yī)學臨床中心、山東省角膜病防治與功能重建技術(shù)工程中心；國家住院醫(yī)師規(guī)范化培訓基地，亞洲角膜病協(xié)會（Asia Cornea Society）國際住院醫(yī)師培訓單位。
設施設備
現(xiàn)有業(yè)務用房3萬平米，核定床位數(shù)142張。投資2億元建成的亞洲最大的角膜病防治中心----山東省角膜病防治研究中心已投入使用。20年來，醫(yī)院已累計從美國、德國、日本等地引進國際先進的大型眼科檢查、治療和手術(shù)設備500余臺(套)。年均投入千萬元用于設備、設施的更新、維護，醫(yī)療服務硬件水平始終處于國內(nèi)領先、國際先進水平。
人才優(yōu)勢
在謝立信院士的引領下，醫(yī)院職工200余名，其中衛(wèi)生專業(yè)技術(shù)人員150余人。建成了一支由山東省醫(yī)學領軍人才、山東省有突出貢獻的中青年專家、山東省泰山學者攀登計劃專家為代表的中高級專業(yè)技術(shù)人員梯隊。醫(yī)師總數(shù)70余人，高級職稱醫(yī)師15名，30%以上醫(yī)生具有國外留學經(jīng)歷和博士學歷，碩士及以上學位人員占比超70%。醫(yī)院歷來重視高端人才的培養(yǎng)與引進。近五年來，先后引進國內(nèi)知名醫(yī)學院校的博士學歷人員10余位。
醫(yī)院業(yè)已形成了以謝立信院士領軍，史偉云教授（國家級行業(yè)領軍人物）為帶頭人，以省級各專業(yè)知名專家為骨干，以博士研究生學歷的青年專家為主體，以一批具有研究生學歷的青年為基礎，年富力強的臨床人才隊伍；具有山東大學、青島大學、濟南大學博士、碩士研究生導師資格10余人，形成了一支潮氣蓬勃的教師隊伍。為醫(yī)院長遠發(fā)展奠定了堅實基礎。
醫(yī)療服務
開設有角膜病、白內(nèi)障、眼底病（內(nèi)、外）、青光眼、眼肌屈光、眼眶病眼整形、角膜屈光科、驗光配鏡（含塑形鏡驗配）等臨床專業(yè)科室。門診設有知名專家門診、專家門診、博士門診、專業(yè)門診，滿足各類患者就診需要?？稍\治各種眼科常見和疑難病。年均接診來自全國30余個省市地區(qū)眼病患者10萬余人次。
醫(yī)院是國內(nèi)較早開展各類角膜移植手術(shù)、白內(nèi)障超聲乳化聯(lián)合人工晶狀體植入術(shù)、青光眼手術(shù)、眼底手術(shù)、近視激光矯正術(shù)的醫(yī)院之一，年均完成各類手術(shù)10000余例。相關技術(shù)均達到國內(nèi)領先、國際先進水平。
特色專長
角膜病專業(yè)：我國角膜病診療、科研的龍頭單位，全國最主要的角膜移植手術(shù)中心之一。我院專家長期擔任中華眼科學分會角膜病學組（代表我國角膜病學術(shù)最高水平的團體）組長。憑借在各種眼部酸堿熱燒傷，真菌、細菌、病毒、棘阿米巴等角膜感染，圓錐角膜、飛秒激光輔助的角膜移植、內(nèi)皮移植等疑難角膜病方面的突出的專家、技術(shù)優(yōu)勢和創(chuàng)新能力，依托國內(nèi)最大的省級紅十字眼庫（也是國內(nèi)首批國際合作眼庫），我院年均提供千余只臨床用角膜材料，每年為來自全國的疑難角膜病患者20000余人解除病痛；完成各類疑難角膜移植手術(shù)1000余臺，占全國角膜移植手術(shù)總量的1/5。
白內(nèi)障及視網(wǎng)膜專業(yè)：常年開展各種復雜的白內(nèi)障摘除手術(shù)，特別是角膜不透明、角膜內(nèi)皮細胞數(shù)低的高危白內(nèi)障手術(shù)；開創(chuàng)白內(nèi)障摘除聯(lián)合25G玻切頭扁平部玻璃體切除術(shù)治療兒童白內(nèi)障手術(shù)。該手術(shù)是現(xiàn)今國內(nèi)眼科界公認最有效、復發(fā)率最低的兒童先天性白內(nèi)障手術(shù)治療方式。現(xiàn)開展的老年性黃斑變性、早中晚期糖尿病性視網(wǎng)膜病變、各種類型視網(wǎng)膜脫離，各種累及眼后段的眼外傷和眼內(nèi)感染，各種病因?qū)е碌难鄣壮鲅约霸绠a(chǎn)兒視網(wǎng)膜病變的診斷和治療也居國內(nèi)領先水平。激光和手術(shù)治療糖尿病視網(wǎng)膜病變、手術(shù)治療各種復雜的視網(wǎng)膜脫離、嚴重眼外傷和眼內(nèi)感染在國內(nèi)具備突出的優(yōu)勢。醫(yī)院依托在角膜病領域無可比擬的超強技術(shù)實力，是國內(nèi)極少數(shù)能夠完成眼部大貫穿手術(shù)（角膜移植聯(lián)合玻璃體切除治療復雜眼外傷等眼前后段聯(lián)合手術(shù)）和利用飛秒激光開展各類個體化近視、散光矯正手術(shù)的醫(yī)療機構(gòu)之一。
科研成果
2011年以來，獲得國家和省部級課題資助60余項，科研經(jīng)費合計2500余萬元。憑借在角膜及眼表手術(shù)方面的多項創(chuàng)新，榮獲國家科技進步二等獎2項，山東省科技進步一等獎等省部級獎勵10余項，居國內(nèi)前五，省內(nèi)之首。
發(fā)表學術(shù)論文300余篇，其中SCI收錄論著133篇，包括Cell Discovery、PNAS、Diabetes等雜志。在世界眼科領域權(quán)威學術(shù)雜志《Ophthalmology》發(fā)表論文10余篇；出版有國內(nèi)唯一的角膜病系列專著一套5本：《角膜病學》《角膜移植學》、《角膜病圖譜》、《臨床角膜病學》、《角膜手術(shù)學》，還聯(lián)合中華醫(yī)學會、人民衛(wèi)生出版社聯(lián)合出版《角膜移植手術(shù)集錦》《先天性白內(nèi)障手術(shù)治療》《常用眼表手術(shù)》《眼前段常規(guī)檢查技術(shù)》等教學光盤和譯著15部。
社會公益
常年深入社區(qū)、學校、農(nóng)村開展眼科科普義診、近視防控篩查及扶貧助困活動，在全省范圍內(nèi)承攬山東省紅十字會“博愛齊魯”白內(nèi)障復明救助項目。10余年來累計開展活動近7000場次，義診群眾超21萬余人，開展公益救助手術(shù)1.1萬余臺，減免各類診療、手術(shù)費用4300余萬元。
2009年，醫(yī)院與山東省紅十字會聯(lián)合成立了角膜捐獻接收組織庫--山東省紅十字眼庫。2020年，山東省衛(wèi)健委依托我院設置山東省眼庫。深度參與全省角膜捐獻接收、宣傳、志愿服務等工作?，F(xiàn)年均完成角膜捐獻接收300余例，是國內(nèi)最大的角膜組織專庫之一。
宗旨目標
自建院起，發(fā)揚“熱愛專業(yè)”的專注精神，艱苦奮斗，堅持自主創(chuàng)新，樹立“為了人類光明”的信念，始終秉持以病人為中心的核心理念，以人為本，以醫(yī)療、科研為重心；不斷發(fā)揮人才、技術(shù)、設備優(yōu)勢，吸收國際先進的管理經(jīng)營理念；贏得了來自國內(nèi)外眼病患者的信賴。醫(yī)院將始終朝著建設服務好、質(zhì)量好、醫(yī)德好，群眾滿意，技術(shù)先進、規(guī)模適度的國內(nèi)領先、國際知名的眼科綜合體不斷前進。
??
院領導班子：
法人代表：史偉云
院? ?長：史偉云
副 院 長：高 華
副 院 長：王 婷
副 院 長：亓曉琳
副 院 長：王富華
副 院 長：原公強
總會計師：吉敦亮
?
Hospital Overview
Shandong Eye Hospital was founded in 2004 by Professor Lixin XIE,an academician of the Chinese Academy of Engineering in ophthalmology, which is an important measure taken by Shandong Provincial Committee and Provincial Government to enlarge and strengthen the “Big Ophthalmology in Shandong” and to increase the Academician Effect, and also a significant step of Shandong Eye Institute to “grow bigger and stronger”. Shandong Eye Hospital is one of the largest state-owned provincial-level Third-grade Class-A specialized eye hospital in China that integrates medical treatment, teaching, scientific research and blindness prevention.
Led by the academician, our hospital has advantages of talents, technology and scientific research, which is prominent in the country and leading in the province. Our hospital was founded by the academician; an expert of our hospital is the vice chairman of the Asia Cornea Society, a member of the Standing Committee of the Ophthalmological Society of Chinese Medical Association and the leader of the Corneal Disease Group. The only specially-invited expert of leading medical talents in Shandong Province also work in our hospital.
The hospital is a leading unit in keratopathy diagnosis, treatment and research in China, and one of the most important corneal transplantation centers in China. Our hospital has outstanding specialists, technical advantages and innovative ability in the treatment of various eye burns, corneal infections, keratoconus, femtosecond laser-assisted corneal transplantation, endothelial transplantation and many other difficult keratopathies. Our hospital is the only unit in China that has published a series of monographs of corneal diseases (a total of 5 monographs, more than 5 million words). It is also an important base for the diagnosis and treatment of difficult cataracts, pediatric cataracts and retinal fundus oculi diseases in China. Our hospital is one of the few hospitals in China that can complete the major surgery of eyes (corneal transplantation combined with vitrectomy for the treatment of complex ocular trauma and other anterior and posterior segment combined surgeries).
Experts of our hospital have published more than 10 papers in Ophthalmology, a TOP academic journal in ophthalmology, ranking first in China. With many innovations in corneal and ocular surface surgeries, our hospital has won two Second Prize in the National Science and Technology Progress Award, being the only one in Shandong province that has won two Second Prize in the National Science and Technology Progress Award in the past 20 years.
Since 2008, our hospital has been approved by the provincial authorities as Shandong Provincial Quality Control Center for Clinical Ophthalmology, Shandong Provincial Medical Center for Clinical Ophthalmology, Shandong Provincial Technological Engineering Center for Corneal Disease Prevention and Functional Reconstruction, National Standardized Training Base for Resident Physician, International Resident Physician Training Unit of Asia Cornea Society.
Facilities and Equipment
Our hospital now has 30,000 square meters for business purpose and 200 opening beds. Shandong Corneal Disease Prevention and Treatment Research Center, the largest corneal disease prevention and treatment center of Asia, built with an investment of 200 million yuan, has been put into use.
Over the past 10 years, our hospital has introduced more than 500 sets of internationally advanced ophthalmic exam, treatment and surgical equipment from the United States, Germany and Japan. An annual investment of 10 million yuan is used for the renewal and maintenance of equipment and facilities. The hardware level of medical services has always been at the leading level in the country and at the advanced level internationally.
Talent Advantage
Under the guidance of Academician Lixin XIE, our hospital has more than 200 employees, more than 150 of whom are medical professionals. A team of mid-level and high-level professionals represented by the leading medical talents in Shandong Province, the young and middle-aged experts with outstanding contributions in Shandong Province and the experts of Taishan Scholar Program of Shandong Province has been built. There are more than 70 physicians in total and 15 of them have senior professional titles. More than 30% of our doctors have foreign study experience and doctoral degree, and over 70% of our doctors have master's degree or above. The hospital has always attached great importance to the cultivation and introduction of high-end talents. In the past five years, our hospital has introduced more than 10 professionals graduated from well-known medical colleges and universities in China with doctoral degree.
With the guidance of Academician Lixin XIE, the hospital has also formed a young and dynamic team of clinical professionals with Professor Weiyun SHI (national industry leader) as the leader, provincial-level leading experts as the backbone, young experts with doctoral degree as the main body and a group of young professionals with master’s degree as the foundation. More than 10 doctors in our hospital are qualified doctoral supervisor or master’s supervisor of Shandong University, Qingdao University or Jinan University, forming a team of teachers full of vigor and vitality. The teams are the solid foundations for the long-term development of our hospital.
Medical Services
Our hospital has many clinical departments, including corneal disease, cataract, fundus disease (internal and external), glaucoma, eye muscle refraction, oculoplastic & orbital surgery, corneal refraction, optometry (including providing optometry services of orthokeratology). Our well-known expert clinics, expert clinics, doctoral clinics and professional clinics can meet the needs of different patients. Our qualified doctors can diagnose and treat a variety of common and difficult ophthalmic diseases. The annual average number of patients with eye diseases coming to our hospital for treatment from more than 30 provinces and cities all over China is more than 100,000.
Our hospital is one of the hospitals in China where various types of corneal transplantation, phacoemulsification combined with intraocular lens implantation, glaucoma surgery, fundus surgery and laser myoporthosis are early performed. More than 10,000 cases of various types of surgeries have been completed annually. The relevant technologies have reached a leading level in the country and an advanced level internationally.
Characteristics and Speciality
Corneal disease subspecialty: Our hospital is a leading unit in the diagnosis, treatment and scientific research of corneal disease in China, and is also one of the most important corneal transplantation centers in China. One of our experts has long served as the leader of the Corneal Disease Group of Ophthalmological Society of Chinese Medical Association (the group representing the highest academic level in corneal diseases in China). With the outstanding experts, technological superiority and innovation ability in various acid, alkali and thermal burns around eyes, corneal infections caused by fungi, bacteria, viruses and acanthamoeba, and difficult corneal diseases including keratoconus, femtosecond laser-assisted corneal surgeries and endothelium transplantation, supported by the largest provincial red cross eye bank in our country (also the first batch of international cooperation eye bank in China), our hospital provides more than a thousand corneal materials for clinical use annually and relieves the pain for more than 20,000 patients with complicated corneal diseases from all over the country every year. Our hospital has completed more than 1,000 various corneal transplantation surgeries, accounting for 20% of the total corneal transplantation surgeries in China.
Cataract and retina subspecialties: Our hospital performs various kinds of difficult cataract surgeries all year round, especially the high-risk cataract surgeries for opaque corneas and corneas with low endothelial cells counts. Our hospital has initiated cataract extraction combined with 25G pars plana vitrectomy for children with cataract, which is now considered as the most effective surgical treatment, with the lowest risks, for children with congenital cataract in ophthalmology in China. Our diagnosis and treatment for age-related macular degeneration, early, middle and late stages of diabetic retinopathy, various types of retinal detachments, various eye traumas and intraocular infections involving the posterior segment, fundus hemorrhage resulting from various causes and retinopathy of prematurity are leading in China. In the treatment of diabetic retinopathy with laser and surgery, surgical treatment of various difficult retinal detachments, severe eye traumas and intraocular infections, our hospital has outstanding advantages in China. Relying on the incomparable strong technical strength in the field of corneal diseases, our hospital is one of the few medical institutions in China that can perform the major surgery of the eye (corneal transplantation combined with vitrectomy for the treatment of complex ocular trauma and other anterior and posterior segment combined surgeries) and can complete various types of individualized myopia and astigmatism correction surgeries using the femtosecond laser.
Scientific Research Achievements
Since 2011, our hospital has received more than 60 national level and provincial level project funds, more than 25 million yuan for scientific research in total. With the innovations in corneal and ocular surface surgeries, our hospital has won two Second Prize in the National Science and Technology Progress Award and more than ten provincial-level awards including a First Prize in the Shandong Science and Technology Progress Award, ranking top five in China and the first in Shandong province.
Our doctors have published more than 300 academic papers, 133 of which are included in SCI, including Cell Discovery,?PNAS (IF: 9.809), Diabetes (IF:8.474) and so on. 12 papers were published in Ophthalmology, the TOP academic journal in ophthalmology.
Our experts have published the only series of monographs on keratopathy in China, including 5 monographs: Cornea, Corneal Transplantation, Corneal Atlas, Clinical Cornea, Surgery of the Cornea and have jointly published 15 teaching CDs and translations such as Collection of Outstanding Corneal Transplant Surgeries, Surgical Treatment of Congenital Cataract, Common Ocular Surface Surgeries and Routine Examination Techniques of Anterior Segment with Chinese Medical Association and People's Medical Publishing House.
Public Interest Activities
Our hospital implements activities helping and supporting the poor in communities and rural areas all year round and has carried out a cataract relief activity called “Great Love in Qilu” in conjunction with Shandong Branch of Red Cross Society of China, covering the whole province. Over the past 10 years, we have helped more than 500 economically disadvantaged families and reduced and remitted more than 3 million diagnosis, treatment and surgery fees.
In 2009, our hospital jointly established a tissue bank for cornea donation and reception with Shandong Branch of Red Cross Society of China, called Eye Bank of Shandong Red Cross, being responsible for the cornea donation and reception work in the 17 cities of Shandong province and assisting the publicity and voluntary services of cornea donation. Our hospital receives about 200 cases of cornea donations annually in Shandong province, making us the biggest cornea tissue bank in China.
Missions and Objectives
Since the establishment of our hospital, we have carried forward the spirit of “l(fā)oving my profession”, worked hard, attached great importance to independent innovation, developed the belief of “fighting for healthy vision”, adhered to the patient-centered core idea and people-oriented principle and focused on medical treatment and scientific research. We have also taken full advantage of the talents, technology and facilities and learnt internationally advanced management concepts. All these efforts have helped us win trust from patients at home and abroad. In the future, our hospital will endeavor unremittingly to evolve into a domestically leading and internationally renowned eye institution that can provide good and high-quality services and have noble medical ethics, advanced technology and moderate scale to satisfy the patients.
?
Leaders of our hospital:
Legal representative: Weiyun SHI
President: Weiyun SHI
Vice president: Hua GAO
Vice president: Ting WANG
Vice president:?Xiaolin QI
Vice president:?Fuhua WANG
Vice president:?Gongqiang YUAN
General accountant: Dunliang JI
?
?組織架構(gòu):
?
醫(yī)院實景圖：
單位資質(zhì)：
?
